The Global Acetazolamide API Market was valued at USD 78.5 Million in 2024 and is projected to reach USD 105.2 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period (2024–2030). This steady growth is primarily driven by the rising global prevalence of glaucoma, altitude sickness, epilepsy, and heart failure, alongside increasing demand for high-purity active pharmaceutical ingredients (APIs) in generic drug formulations.

As the pharmaceutical industry continues to emphasize stringent quality control and reliable supply chains for essential medicines, the role of API manufacturers becomes increasingly critical. In this blog, we profile the Top 10 Companies in the Acetazolamide API Industry—a group of established pharmaceutical giants and specialized chemical producers ensuring the global supply of this vital therapeutic agent.

Download FREE Sample Report:
Acetazolamide API Market – View in Detailed Research Report

---

🔟 1. Teva API

Headquarters: Tel Aviv, Israel
Key Offering: High-Purity Acetazolamide API (≥99.9%)

Teva API, the active pharmaceutical ingredient division of Teva Pharmaceutical Industries Ltd., is one of the world’s largest API manufacturers. The company produces a vast portfolio of generic APIs, including acetazolamide, and supplies them to pharmaceutical companies globally. Its scale and vertical integration provide a significant advantage in the market.

Quality and Manufacturing Initiatives:

• Global manufacturing facilities compliant with FDA, EMA, and other major regulatory standards

• Significant investment in continuous manufacturing and process optimization technologies

• Focus on supply chain resilience and security for essential medicines

---

9️⃣ 2. CR Double-Crane Pharmaceuticals

Headquarters: Beijing, China
Key Offering: Acetazolamide API, Acetazolamide Tablets

CR Double-Crane Pharmaceuticals is a leading Chinese pharmaceutical company with a strong focus on cardiovascular, cerebrovascular, and metabolic diseases. The company manufactures the acetazolamide API and also formulates it into finished dosage forms, providing an integrated supply solution.

Quality and Manufacturing Initiatives:

• Extensive R&D focused on process improvement and impurity profiling

• Strong domestic market presence with expanding international footprint

---

8️⃣ 3. Polpharma

Headquarters: Starogard Gdański, Poland
Key Offering: Acetazolamide API for European Markets

Polpharma is a major European pharmaceutical manufacturer with a substantial API business. The company is a key supplier of acetazolamide API within Europe, adhering to the strict regulatory requirements of the European Medicines Agency (EMA).

Quality and Manufacturing Initiatives:

• State-of-the-art manufacturing plants with a focus on environmental sustainability

• Strategic focus on supplying high-quality APIs to the European generics market

---

7️⃣ 4. Cambrex Corporation

Headquarters: East Rutherford, New Jersey, USA
Key Offering: cGMP Acetazolamide API for North American Markets

Cambrex is a leading contract development and manufacturing organization (CDMO) specializing in small molecule APIs. The company provides high-quality, cGMP-compliant acetazolamide API, serving both innovator and generic pharmaceutical companies, particularly in North America.

Quality and Manufacturing Initiatives:

• Expertise in controlled substances and complex API manufacturing

• Robust analytical development and quality control services

Download FREE Sample Report:
Acetazolamide API Market – View in Detailed Research Report

---

6️⃣ 5. CTX Lifesciences

Headquarters: Hyderabad, India
Key Offering: Acetazolamide API (Various Grades)

CTX Lifesciences is an Indian-based company engaged in the development and manufacturing of APIs and intermediates. It has established itself as a reliable supplier of acetazolamide, leveraging India’s cost-effective and skilled chemical manufacturing base.

Quality and Manufacturing Initiatives:

• Manufacturing facilities approved by regulatory agencies across emerging markets

• Focus on scalability and cost-efficient production processes

---

5️⃣ 6. Emcure Pharmaceuticals

Headquarters: Pune, India
Key Offering: Acetazolamide API and Finished Formulations

Emcure Pharmaceuticals is a prominent Indian pharmaceutical company with a strong vertical integration strategy. It manufactures its own APIs, including acetazolamide, for use in its diverse portfolio of branded generic medicines sold in over 70 countries.

Quality and Manufacturing Initiatives:

• World-class manufacturing plants compliant with international regulatory standards

• Significant investment in biotech and new chemical entity development

---

4️⃣ 7. NAKODA CHEMICALS LIMITED

Headquarters: Mumbai, India
Key Offering: Industrial and Pharmaceutical Grade Acetazolamide

Nakoda Chemicals Limited specializes in the manufacturing of bulk drugs, intermediates, and APIs. The company produces acetazolamide and serves a global clientele, competing on both quality and price in the competitive API market.

Quality and Manufacturing Initiatives:

• Dedicated R&D center focused on process innovation

• Strategic focus on expanding its portfolio of niche APIs

---

3️⃣ 8. Osmopharm

Headquarters: Gland, Switzerland
Key Offering: High-Purity Acetazolamide for European Pharmacopoeia Standards

Osmopharm is a Swiss company specializing in the sourcing and distribution of pharmaceutical raw materials, including APIs. While not always a primary manufacturer, it acts as a critical supplier and quality guarantor of acetazolamide API that meets the stringent specifications of the European Pharmacopoeia.

Quality and Manufacturing Initiatives:

• Rigorous supplier qualification and quality auditing processes

• Expertise in navigating complex EU regulatory requirements

---

2️⃣ 9. Regis Technologies

Headquarters: Morton Grove, Illinois, USA
Key Offering: cGMP Acetazolamide for Pharmaceutical R&D and Commercial Use

Regis Technologies is a US-based CDMO specializing in chromatographic purification and the production of high-potency APIs (HPAPIs) and other complex molecules. They offer contract manufacturing services for acetazolamide, focusing on high-purity batches for critical applications.

Quality and Manufacturing Initiatives:

• Leadership in chromatographic separation technologies

• Strong capabilities in producing APIs for clinical trial materials

---

1️⃣ 10. Sneha Medicare

Headquarters: Hyderabad, India
Key Offering: Acetazolamide API and Key Intermediates

Sneha Medicare is an Indian company engaged in the manufacturing of APIs and their intermediates. It is a recognized player in the acetazolamide supply chain, providing cost-effective options for generic drug manufacturers worldwide.

Quality and Manufacturing Initiatives:

• Focus on backward integration to control the supply of key starting materials

• Commitment to maintaining competitive pricing while ensuring regulatory compliance

Get Full Report Here:
Acetazolamide API Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Acetazolamide API Is Driven by Quality and Supply Chain Resilience

The acetazolamide API market is characterized by a stable demand profile, but it is undergoing a significant transformation. The focus is shifting from merely meeting volume requirements to ensuring uncompromising quality, robust supply chains, and adherence to increasingly stringent global regulations.

📈 Key Trends Shaping the Market:

• Increasing regulatory scrutiny on impurity profiles (e.g., nitrosamines) driving advanced analytical testing

• Growing demand for “green chemistry” and sustainable manufacturing processes in API production

• Strategic partnerships between generic drugmakers and API suppliers for long-term supply security

• Expansion of pharmaceutical production in Asia-Pacific, making regional API suppliers more prominent

Get Full Report Here:
Acetazolamide API Market – View in Detailed Research Report

The companies listed above are not only supplying a critical therapeutic ingredient—they are upholding the quality and reliability standards that underpin global healthcare systems.